In these extraordinary times, we want to support both the drive for research into COVID-19 and all our partners across the world as they face disruption in both their professional and personal lives. This includes the global library community and you, in your role as a librarian.
In order to do this, below are key links and information. Read on for more and should you have any questions our customer service teams are on hand to help at: [email protected].
As scholarly publishers, the work we do in partnership with editors, scholarly societies and librarians to curate, make discoverable and rapidly disseminate research means we have a critical role to play in the current emergency.
Our CEO, Annie Callanan, outlines how we have been working to provide the research community with free access to COVID-19 research.
We have also launched a resource center to bring together COVID-19 journal and book resources. This is being updated daily, based on keyword scans of journal papers in production to ensure that we are making all COVID-19 research free to access at the point of publication.
We understand that many of you, along with your library users, will be making adjustments to your professional lives as you switch to working from home and adapt to remote teaching.
We do not anticipate any disruption to service on our Taylor & Francis Online and Taylor & Francis Ebooks platforms. Our staff are on hand to help if users are experiencing any difficulties with remote access, and we will ensure that guidance on how to do this remains updated.
Read instructions on enabling remote access for Taylor & Francis Online
We are currently in the process of adding additional options to support off-campus access and will be updating this page as these become available. We will also update you by email too.
See our guidance on how to enable remote access authentication for ebooks on Taylor & Francis eBooks
We will continue to work with all of our stakeholders through this crisis to champion trusted, peer-reviewed research and ensure it is made available as rapidly as possible to enable those involved in policymaking to make informed decisions, and to expedite drug discovery and treatments to help those who are most in need.